Table 1.
Demographic data and clinical stage of the tumor:
| Factor | Number (%) | Number (%) |
|---|---|---|
|
| ||
| Demographics: | ||
| Male/Female | 69 (64%)/39 (36%) | |
| Median age at diagnosis | 62 (20–89) | |
| Primary tumor site | ||
| Oral cavity | 77 (71.3%) | |
| Oropharynx | 24 (22.2%) | |
| Larynx | 5 (4.6%) | |
| Hypopharynx | 1 (0.9%) | |
| Nasopharynx | 1 (0.9%) | |
|
| ||
| Staging: | ||
| T Stage | Clinical | Pathological |
| Tx | 14 (13%) | 10 (9.3%) |
| T1 | 16 (14.8%) | 32 (29.6%) |
| T2 | 48 (44.4%) | 29 (26.9%) |
| T3 | 10 (9.3%) | 10 (9.3%) |
| T4 | 20 (18.5%) | 27 (25%) |
| Nodal Stage | ||
| N1 | 55 (50.9%) | 39 (36.1%) |
| N2A | 9 (8.3%) | 6 (5.6%) |
| N2B | 33 (30.6%) | 48 (44.4%) |
| N2C | 11 (10.2%) | 15 (13.9%) |
| Overall | ||
| III | 32 (29.6%) | |
| IVa | 76 (70.4%) | |
|
| ||
| Extent of neck dissection: | ||
| Ipsilateral Neck (108) | Contralateral Neck (23) | |
| I-III (Supraomohyoid) | 12 (11.1%) | 4 (3.7%) |
| I-IV (Anterolateral) | 86 (79.6%) | 13 (12.1%) |
| II-IV (Lateral) | 5 (4.6%) | 6 (5.5%) |
| II-V (posterolateral) | 5 (4.6%) | |
|
| ||
| Pathology details: | ||
| Median number of nodes removed: | 32 (4–101) | |
| Median number of positive nodes: | 2 (1–19) | |
| Extracapsular Spread: | 38 (35.2%) | |
| Positive surgical margins at the primary site | 12 (11.1%) | |
|
| ||
| Adjuvant Treatments: | 95 (88%) | |
| Radiation | 50 (46.3%) | |
| Chemoradiation | 42 (38.9%) | |
| Chemotherapy | 3 (2.8%) | |